Wealth Management Associates’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Wealth Management Associates’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-295,800	Closed	-$73K	–	264
2026 Q1	$73K	Sell	295,800 -20,000	-6%	-$7.96K	0.03%	233
2025 Q4	$133K	Sell	315,800 -20,000	-6%	-$10.6K	0.05%	232
2025 Q3	$226K	Buy	335,800 +28,000	+9%	+$15.1K	0.08%	208
2025 Q2	$167K	Buy	307,800 +79,400	+35%	+$47.1K	0.06%	209
2025 Q1	$150K	Buy	228,400 +155,600	+214%	+$165K	0.06%	205
2024 Q4	$74.3K	Buy	+72,800	New	+$133K	0.03%	207

Other funds holding SGMO

AIM

Axiom Investment Management New York $150M AUM

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Wealth Management Associates's SGMO Position: Q2 2026 in Review

Wealth Management Associates sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 295,800 shares — an estimated $73K sold.

Wealth Management Associates first reported a position in SGMO in Q4 2024 and held it in 6 quarters. The position peaked at $226K in Q3 2025. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Wealth Management Associates reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Wealth Management Associates sold 295,800 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $73K.
Wealth Management Associates first reported a position in SANGAMO THERAPEUTICS INC in Q4 2024 and held it in 6 quarters.
Wealth Management Associates's SANGAMO THERAPEUTICS INC position peaked at $226K in Q3 2025.
2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Wealth Management Associates's 13F filing for Q2 2026, filed 21 Jul 2026.